HomeNewsBusinessAviation Turbine Fuel price cut by 14% from March 21: Report

Aviation Turbine Fuel price cut by 14% from March 21: Report

The move will bring some relief to airlines, which are suffering from a weak demand because of COVID-19

March 21, 2020 / 13:41 IST
Story continues below Advertisement

The price of Aviation Turbine Fuel (ATF) will be reduced by 14 percent from March 21, sources told CNBC-TV18.

Story continues below Advertisement

As of March 1, one kilolitre of ATF was available in Delhi at Rs 56,859.01 and in Mumbai for Rs 56,400.74. Similarly, the price of one kilolitre ATF in Chennai was at Rs 58,875.63 and Rs 62,160. 48 in Kolkata. These prices are set to be reduced by nearly 14 percent from March 21 onwards.

Conventionally, prices of ATF are revised on the first of every month. But, airlines have been appealing to the government to revise prices every week so that they can benefit from the decline in global prices of crude oil.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show